Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Wellness Times.
Press releases published on April 14, 2025

AQUA Developments’ The Central Downtown Wins Big at International Property Awards!
DUBAI, United Arab Emirates, April 14, 2025 (GLOBE NEWSWIRE) -- AQUA Developments’ flagship project, The Central Downtown, has won the esteemed “Best Mixed-Use Development Arabia” at the International Property Awards 2025, held in London. This prestigious …

United Bank and Federal Home Loan Bank of Atlanta Award $4.7 Million to Support Affordable Housing in Washington, D.C. and Virginia
WASHINGTON, April 14, 2025 (GLOBE NEWSWIRE) -- United Bank (NASDAQ: UBSI) and the Federal Home Loan Bank of Atlanta (FHLBank Atlanta) announced today an investment of $4.7 million in grant funding, designated for five separate projects that will create 363 …

The Krill Meal Market to Reach $259.7 Million by 2027 in the short term and $416.5 Million by 2035 Globally, at 6.0% CAGR: Allied Market Research
Wilmington, Delaware, April 14, 2025 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “Krill Meal Market -Global Opportunity Analysis and Industry Forecast, 2024-2035", valued at US$208.4 million in 2023. With a projected CAGR of 6.0% …

VIVUS Announces Enrollment of First Patient in Phase 2 Clinical Trial Assessing Ethanol-Free Carmustine as a Component of High-Dose Chemotherapy Prior to Transplant in Patients with Hodgkin or Non-Hodgkin Lymphoma
— Innovative ethanol-free formulation intended to provide improved safety and advance care for patients undergoing high-dose conditioning therapy prior to autologous hematopoietic cell transplantation (AHCT) — First patient dosed at City of Hope National …

NeuroOne® OneRF® Technology Success Story Featured on Fox News
Pediatric Patient Treated with OneRF® Ablation System Goes From Up to 10 Nightly Seizures to Zero EDEN PRAIRIE, Minn., April 14, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical …

Edible Garden Signs Exclusive Distribution Agreement with Midwest Retailer
Joins Forces with Berkot’s to Leverage Patented Self-Watering Display Technology to Drive Freshness …

ASUS Announces ExpertBook P1, P3 and P5 Now Available in Canada
TORONTO, April 14, 2025 (GLOBE NEWSWIRE) -- ASUS today announced that the new ExpertBook P1 (P1403 and P1503) laptop models are now available in Canada through the ASUS Store, selected retailers, and B2B channels. These additions join the high-performance …

Free Oral Cancer Screenings in Honor of Oral, Head and Neck Cancer Awareness Month
IRVING, Texas, April 14, 2025 (GLOBE NEWSWIRE) -- In honor of Oral, Head and Neck Cancer Awareness Month, 26 U.S. Oral Surgery Management surgeon partners in seven states will offer free oral cancer screenings during the week of April 14. The screenings …

Regional Health Properties Reports Fourth Quarter & Full Year 2024 Financial Results
ATLANTA, GA, April 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (the “Company”, “Regional”, “we”, “us” or “our”) (OTCQB: RHEP) (OTCQB: RHEPB) (OTCQB: RHEPA), a self-managed healthcare real estate investment company that invests primarily …

Verano Announces Promotion and Appointment of Richard Tarapchak as Chief Financial Officer
Tarapchak brings more than 30 years of accounting and finance expertise to the role CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today …

UPDATE -- Relmada Therapeutics To Present NDV-01 Data at AUA2025
CORAL GABLES, Fla., April 14, 2025 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada”, “the Company”), a clinical-stage biotechnology company, today announced the presentation of an abstract at the American Urology Association (AUA2025 …

Clene to Present at the Emerging Growth Conference
SALT LAKE CITY, April 14, 2025 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to advancing therapies for …

Home Products Industry Forecasted to Grow Over Next Three Years, Reports Circana
CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- CHICAGO, Apr. 14, 2025 – The U.S. home products industry closed out 2024 with a 1% increase in sales, and growth is expected to continue through 2027. The forecast is for the overall demand for home products in …

Can-Fite to Generate $685M in Projected Future Revenues from its Partnerships
Ramat Gan, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs for oncological and inflammatory diseases, today announced …

Healthy Choice Wellness Corp. Announces Same-Store Sales Growth as Part of its Record First Quarter 2025 Sales and Gross Profit Performance
HOLLYWOOD, FL, April 14, 2025 (GLOBE NEWSWIRE) -- Healthy Choice Wellness Corp. (“HCWC” or the “Company”) (NYSEAM: HCWC), a holding company operating 19 natural and organic grocery stores across six states, today announced record first-quarter 2025 sales …

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing
RADNOR, Pa., April 14, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced the launch of its Non-Animal Navigator™ solution designed to help biopharmaceutical companies lead the …

Longevity Health Holdings Announces Execution of Merger Agreement With 20/20 Biolabs
PITTSBURGH, Pa. …

Boostaro Reviews: Best Male Enhancement Supplement? Is Boostaro Capsules Safe?
AURORA, Colo., April 14, 2025 (GLOBE NEWSWIRE) -- Boostaro currently enjoys a prominent position in the market as one of the most efficacious health products available. This product employs a robust blend of organic ingredients that synergistically enhance …

Can-Fite Reports 2024 Financial Results and Clinical Update
RAMAT GAN, Israel, April 14, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today …

NKGen Biotech To Present on the Use of Troculeucel for Alzheimer’s and Parkinson’s Disease at the 7th China International Biotechnology Conference & Exhibition
SANTA ANA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic natural killer …